Sulphate cartilage is selling well behind the scenes

do not have to wait until the "double eleven", overseas purchase of cartilage sulfate orders have let the major e-commerce earn pot full. What many others expect, however, is that China is the world's largest producer and exporter of cartilage sulfate.
Liu Zhanglin, vice president of the China Medical and Health Import and Export Chamber of Commerce, has revealed that China's production of cartilage sulfate reached
7465
tons in
, accounting for
80% of the world market capacity
in developed countries, osteoarthritis is the most common joint disease. The most common symptoms are joint pain and loss of function caused by cartilage damage. More than
30 million people
the United States suffer from osteoarthritis, resulting in social spending of more than $
60 billion
year. As a slow-acting drug for osteoarthritis, the clinical efficacy of choline sulfate is shown in: reducing joint pain, improving joint function, and reducing the consumption of nonsteroidal anti-inflammatory or painkillers.china was first put into operation in 1958 by
Southwest Pharmaceutical
In 1958. Because it is by extraction method production, over the years, China's production enterprises are not many, production and scale are also very small, the general production capacity of enterprises only a few hundred kilograms. In the mid-
90s
, the raw materials used in Europe, North America and other places mainly came from locally raised cattle, sheep and other animals, affected by "mad cow disease", Europe and the United States and other countries to purchase pig cartilage processing and production of chone sulphate. By virtue of its resource advantages, China has quickly become an important output of cartilage sulfate in the world.

10
from the mid-
to the mid-1990s to
2006-
was a period of rapid development for China's cartilage sulfate industry, with production rapidly expanding from
1
tons to
1990
tons.the world's main demand countries for cartilage sulfate include the United States, Canada, Europe, Japan, South Korea. In the
, the
FDA
identifies cartilage or joint protection agents such as cartilage sulphate as dietary supplements, not medicines, primarily to relieve symptoms of joint discomfort and protect cartilage tissue. In Europe, sulphate cartilage
/
amino glucose has been used as a prescription or over-the-counter treatment for osteoarthritis for more than
20,
years and has been approved as a government-compensated health insurance. In Australia, sulphate cartilage is mainly used in nutritional health drugs for the prevention and treatment of osteoarthritis and is classified as an auxiliary drug and managed by the Drug Administration of the Federal Ministry of Health. In Japan, cartilage sulfate is an over-the-counter drug, eye drops are used to replenish tears or protect the cornea, and oral preparations are used for joint pain relief.strong demand in the international market, China's sulphate cartilage industry has grown rapidly.
2006

average annual output in 2006-
was
3300
tons, with a compound annual growth rate of
24%
.
production of
sulphate has continued to rise since 2010.
reached
4545
tons in
,

5360
tons in 2011
,

6325
tons in
2012 and
7465
tons in

2013
while production is increasing rapidly, the number of enterprises is also increasing, and the number of domestic sulphate cartilage enterprises has increased from
38
production enterprises in
2002-
to nearly
200
enterprises. However, the concentration of industrial brands is also increasing.a total of
31,
production approval numbers for cartilage sulfate raw materials, more than
100,
preparation production approval numbers,
17
enterprises have passed the
GMP
certification of sulphate cartilage raw materials. However, in the last
3
applications for sulphate cartilage products, preparations are mostly eye drops, oral sulphate cartilage nutritional care products and drug markets are far from open.in fact, in addition to acting as cartilage protectors to repair joints and delay their progressive degradation, cartilage sulfate has developed some new features in recent years. For example, its anti-blood coagulation effect can be used for cardiovascular care, lubrication can be used for ophthalmic care, external use can also be used for mucous membrane damage and wound healing.However, due to the domestic current health food regulations do not assist in improving joint discomfort and other functions, domestic cartilage sulfate can only be used to increase bone density health food development, which greatly limits the application of cartilage sulfate. With the increasing trend of aging in China, joint problems have become an important factor affecting the quality of life of the elderly. According to statistics, by
2020
, China's elderly population will exceed
150 million, while about

50% of the
60
-year-olds
are suffering from osteoarthritis and other joint diseases. Drawing on the mature market applications and broad market demand in North America and other places, the addition of health food functions related to improving joint discomfort can not only improve the quality of life of the majority of middle-aged and elderly people, but also guide the steady growth and sustainable development of the health food industry with cartilage sulfate.there are about
355
million people with multiple osteoarthritis in the world, and more than

million people with osteoarthritis in China, and the incidence of osteoarthritis will increase as the average life expectancy of human beings increases. Experts at home and abroad are focusing on the development of osteoarthritis has the exact improvement and therapeutic effect of sulphate cartilage end products, sulphate cartilage development has broad application prospects.